Prevalence of Antiphospholipid Antibodies Among Women With Preeclampsia
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Preeclampsia
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Cross-Sectional
Participation Requirements
- Age
- Between 20 years and 35 years
- Gender
- Only males
Description
For all women included in the study, blood samples will be tested for anticardiolipin antibodies and lupus anticoagulant. The clinical details of all women will be collected by reviewing their hospital and prenatal records. The following clinical characteristics will be evaluated: maternal age, prev...
For all women included in the study, blood samples will be tested for anticardiolipin antibodies and lupus anticoagulant. The clinical details of all women will be collected by reviewing their hospital and prenatal records. The following clinical characteristics will be evaluated: maternal age, previous gestations, parity, past or family history of preeclampsia, gestational age at the onset of preeclampsia, gestational age at delivery and birth weight. The following pregnancy and delivery complications will be assessed: placental insufficiency, intrauterine growth restriction, fetal loss (stillbirth) and early neonatal death.
Tracking Information
- NCT #
- NCT02699437
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Hanaa M El-Shafiey Mansoura University Study Director: Mohamed S Abdelhafez, Dr Mansoura University Study Director: Alaa El-Din M El-Gohary, Dr Mansoura University Study Chair: El-Said M Abd El-Hady, Prof Mansoura University
Get Well Soon